Literature DB >> 7499755

Relapse of herpes simplex encephalitis.

M A Barthez-Carpentier1, F Rozenberg, E Dussaix, P Lebon, A Goudeau, C Billard, M Tardieu.   

Abstract

We report five children who had recurrent central nervous system signs after conventional acyclovir therapy for herpes simplex encephalitis. Secondary exacerbation was characterized clinically by severe ballismic movement disorder in all five children, associated with fever, impairment of consciousness, and seizures. Biologic analysis in all children and magnetic resonance imaging and neuropathology studies of the brain in three cases were compatible with inflammatory reaction. In contrast, all viral cultures remained negative, herpes simplex virus antigen in one child and DNA tested by polymerase chain reaction in four children were undetectable in the first samples of cerebrospinal fluid during the relapse, suggesting a postinfectious, immune-mediated mechanism of relapse in these patients.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7499755     DOI: 10.1177/088307389501000504

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  15 in total

Review 1.  Non-traumatic coma in children.

Authors:  F J Kirkham
Journal:  Arch Dis Child       Date:  2001-10       Impact factor: 3.791

2.  Experimental herpes simplex virus encephalitis: a combination therapy of acyclovir and glucocorticoids reduces long-term magnetic resonance imaging abnormalities.

Authors:  Uta K Meyding-Lamadé; Christoph Oberlinner; Philipp R Rau; Sonja Seyfer; Sabine Heiland; Johann Sellner; Brigitte T Wildemann; Wolfram R Lamadé
Journal:  J Neurovirol       Date:  2003-02       Impact factor: 2.643

3.  Severe chorea with positive anti-basal ganglia antibodies after herpesencephalitis.

Authors:  I Marschitz; S Rödl; U Gruber-Sedlmayr; A Church; G Giovannoni; G Zobel; C J Mache; J Raith; B Plecko
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-01       Impact factor: 10.154

Review 4.  Herpes Simplex Virus-1 Encephalitis in Adults: Pathophysiology, Diagnosis, and Management.

Authors:  Michael J Bradshaw; Arun Venkatesan
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

5.  HSV encephalitis-induced anti-NMDAR encephalitis in a 67-year-old woman: report of a case and review of the literature.

Authors:  Nicholas A Morris; Tamara B Kaplan; Jenny Linnoila; Tracey Cho
Journal:  J Neurovirol       Date:  2015-07-03       Impact factor: 2.643

6.  Incidence and pathogenesis of clinical relapse after herpes simplex encephalitis in adults.

Authors:  B Sköldenberg; E Aurelius; A Hjalmarsson; F Sabri; M Forsgren; B Andersson; A Linde; O Strannegård; M Studahl; L Hagberg; L Rosengren
Journal:  J Neurol       Date:  2005-10-17       Impact factor: 4.849

Review 7.  Update on herpes virus infections of the nervous system.

Authors:  Israel Steiner; Felix Benninger
Journal:  Curr Neurol Neurosci Rep       Date:  2013-12       Impact factor: 5.081

8.  A case of unilateral hemispheric encephalitis.

Authors:  S H Heo; M-S Lee; T B Ahn; K C Park; S S Yoon; D I Chang; K C Chung
Journal:  Neurol Sci       Date:  2007-08-10       Impact factor: 3.307

9.  Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis.

Authors:  Thaís Armangue; Marianna Spatola; Alexandru Vlagea; Simone Mattozzi; Marc Cárceles-Cordon; Eloy Martinez-Heras; Sara Llufriu; Jordi Muchart; María Elena Erro; Laura Abraira; German Moris; Luis Monros-Giménez; Íñigo Corral-Corral; Carmen Montejo; Manuel Toledo; Luis Bataller; Gabriela Secondi; Helena Ariño; Eugenia Martínez-Hernández; Manel Juan; Maria Angeles Marcos; Laia Alsina; Albert Saiz; Myrna R Rosenfeld; Francesc Graus; Josep Dalmau
Journal:  Lancet Neurol       Date:  2018-07-23       Impact factor: 44.182

10.  Clinical Neuropathology practice guide 4-2013: post-herpes simplex encephalitis: N-methyl-Daspartate receptor antibodies are part of the problem.

Authors:  Romana Höftberger; Thaís Armangue; Frank Leypoldt; Francesc Graus; Josep Dalmau
Journal:  Clin Neuropathol       Date:  2013 Jul-Aug       Impact factor: 1.368

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.